Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012
A Meijer1, M Jonges, P van Beek
1Laboratory for Infectious Diseases and Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. adam.meijer@rivm.nl
Abstract:
Two Dutch travellers were infected with oseltamivir-resistant influenza A(H1N1)pdm09 viruses with an H275Y neuraminidase substitution in early August 2012. Both cases were probably infected during separate holidays at the Catalonian coast (Spain). No epidemiological connection between the two cases was found, and neither of them was treated with oseltamivir before specimen collection. Genetic analysis of the neuraminidase gene revealed the presence of previously described permissive mutations that may increase the likelihood of such strains emerging and spreading widely.
Insights
Two Dutch travellers contracted oseltamivir-resistant influenza A(H1N1)pdm09 virus infections. The neuraminidase H275Y substitution suggests potential for widespread emergence of resistant strains.
Area of Science:
- Virology
- Epidemiology
- Antimicrobial Resistance
Background:
- Influenza A(H1N1)pdm09 is a significant human pathogen.
- Oseltamivir is a key antiviral medication used for influenza treatment.
- Neuraminidase inhibitors are crucial for managing influenza outbreaks.
Observation:
- Two unrelated Dutch travellers were diagnosed with oseltamivir-resistant influenza A(H1N1)pdm09 in August 2012.
- Infections were likely acquired during separate holidays on the Catalonian coast, Spain.
- No prior oseltamivir treatment or epidemiological link was identified between the cases.
Findings:
- Genetic analysis identified the H275Y substitution in the neuraminidase gene, conferring oseltamivir resistance.
- Permissive mutations were also detected, potentially facilitating the emergence and spread of resistant strains.
- This indicates a spontaneous emergence of resistant influenza strains independent of patient treatment.
Implications:
- The findings highlight the potential for rapid evolution of antiviral resistance in influenza viruses.
- This underscores the need for continuous surveillance of drug-resistant influenza strains.
- Public health strategies may need to adapt to the growing threat of oseltamivir-resistant influenza.
Related Concept Videos
Influenza
Infectious Diseases and Their Occurrence
Viral Recombination


